Role of site-specific DNA demethylation in TNFα-induced MMP9 expression in keratinocytes

Journal of Molecular Endocrinology

Volumn 50, Issue 3, 2013, Pages 279-290

  Ling, Li ^a   Ren, Meng ^a   Yang, Chuan ^a   Lao, Guojuan ^a   Chen, Lihong ^a   Luo, Hengcong ^a   Feng, Zhimei ^a   Yan, Li ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetic foot ulcers; Keratinocytes; Matrix metalloproteinase 9; Site specific DNA demethylation; Tumor necrosis factor a

Indexed keywords

BISULFITE; GELATINASE B; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DIABETES MELLITUS; DIABETIC FOOT; DNA METHYLATION; GANGRENE; HUMAN; HUMAN CELL; KERATINOCYTE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; SITE SPECIFIC DNA DEMETHYLATION; TRANSCRIPTION INITIATION SITE; WOUND HEALING;

EID: 84876185597     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0172     Document Type: Article

References (31)

1. Ahmad J, Zubair M & Malik A 2012 Cathepsin-D, adiponectin, TNF-a, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: a multicentric study. Foot 22 194-199.(doi::10.1016/j.foot.2012.03.015)
2. Bahar-Shany K, Ravid A & Koren R 2009 Upregulation of MMP-9 production by TNFa in keratinocytes and its attenuation by vitamin D. Journal of Cellular Physiology 222 729-737.(doi::10.1002/jcp.22004)
3. Balic M, Pichler M, Strutz J, Heitzer E, Ausch C, Samonigg H, Cote RJ & Dandachi N 2009 High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative highresolutionmelting analysis. Journal of Molecular Diagnostics 11 102-108.(doi:10.2353/jmoldx.2009.080109)
4. Bhutani N, Burns David M & Blau Helen M 2011 DNA demethylation dynamics. Cell 146 866-872.(doi::10.1016/j.cell.2011.08.042)
5. Boukamp P, Petrussevska R, Breitkreutz D, Hornung J & Markham A 1988 Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology 106 761-771.(doi:10.1083/jcb.106.3.761)
6. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G & Apelqvist J 2005 The global burden of diabetic foot disease. Lancet 366 1719-1724.(doi:10.1016/S0140-6736(05)67698-2)
7. Brandner JM, Sanchis A, Alba L, Latorre V, Sevilla LM & Pérez P 2012 Keratinocyte-targeted overexpression of the glucocorticoid receptor delays cutaneous wound healing. PLoS ONE 7 e29701.(doi::10.1371/journal.pone.0029701)
8. Chicoine E 2002 Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochemical and Biophysical Research Communications 297 765-772.(doi::10.1016/S0006-291X (02)02283-0)
9. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME & Brownlee M 2008 Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. Journal of Experimental Medicine 205 2409-2417.(doi:10.1084/jem.20081188)
10. Fujita N, Shimotake N, Ohki I, Chiba T, Saya H, Shirakawa M & Nakao M 2000 Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Molecular and Cellular Biology 20 5107-5118.(doi:10.1128/MCB.20.14.5107-5118.2000)
11. Fürst RW, Kliem H, Meyer HHD & Ulbrich SE 2012 A differentially methylated single CpG-site is correlated with estrogen receptor a transcription. Journal of Steroid Biochemistry and Molecular Biology 130 96-104.(doi::10.1016/j.jsbmb.2012.01.009)
12. Hashimoto K, Oreffo ROC, Gibson MB, Goldring MB & Roach HI 2009 DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis and Rheumatism 60 3303-3313.(doi::10.1002/art.24882)
13. Hotamisligil G & Spiegelman B 1994 Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 43 1271-1278.(doi:10.2337/diabetes.43.11.1271)
14. Klug M & Rehli M 2006 Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1 127-130.(doi:10.4161/epi.1.3.3327)
15. Kondo Y 2004 Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. PNAS 101 7398-7403.(doi::10.1073/pnas.0306641101)
16. Kondo Y, Shen L, Yan P, Huang T & Issa J-P J 2004 Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. PNAS 101 7398-7403.(doi:10.1073/pnas.0306641101)
17. Landis RC, Evans BJ, Chaturvedi N & Haskard DO 2010 Persistence of TNFa in diabetic wounds. Diabetologia 53 1537-1538.(doi::10.1007/s00125-010-1766-0)
18. Ling C & Groop L 2009 Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58 2718-2725.(doi:10.2337/db09-1003)
19. Liu Y, Min D, Bolton T, Nube V, Twigg SM, Yue DK & McLennan SV 2009 Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care 32 117-119.(doi::10.2337/dc08-0763)
20. McLennan S, Min D & Yue D 2008 Matrixmetalloproteinases and their rolesin poor wound healing in diabetes. Wound Practice and Research 16 116-121.
21. Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca' L & Ferrannini E 2006 Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 55 1133-1140.(doi:10.2337/diabetes.55.04.06.db05-1076)
22. Olsen A, Sarras M, Leontovich A & Intine R 2012 Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 61 485-491.(doi:10.2337/db11-0588)
23. Reiss M, Han Y & Garcia E 2010 Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 147 295-302.(doi::10.1016/j.surg.2009.10.016)
24. Roach HI, Yamada N, Cheung KSC, Tilley S, Clarke NMP, Oreffo ROC, Kokubun S & Bronner F 2005 Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis and Rheumatism 52 3110-3124.(doi::10.1002/art.21300)
25. Sawicki G, Marcoux Y, Sarkhosh K, Tredget EE & Ghahary A 2005 Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Molecular and Cellular Biochemistry 269 209-216.(doi::10.1007/s11010-005-3178-x)
26. Simon R, Britsch S & Bergemann A 2011 Ablation of Sax2 gene expression prevents diet-induced obesity. FEBS Journal 278 371-382.(doi::10.1111/j.1742-4658.2010.07960.x)
27. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L & Natarajan R 2008 Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. PNAS 105 9047-9052.(doi::10.1073/pnas.0803623105)
28. Wu SC & Zhang Y 2010 Active DNA demethylation: many roads lead to Rome. Nature Reviews. Molecular Cell Biology 11 607-620.(doi::10.1038/nrm2950)
29. Yan C & Boyd D 2006 Regulationofmatrixmetalloproteinase gene expression. Journal of Cellular Physiology 211 19-26.(doi::10.1002/jcp.20948)
30. Yang C, Zhu P & Yan L 2009 Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats. Journal of the American Podiatric Medical Association 99 489-496.
31. Zubair M, Malik A & Ahmad J 2012 Plasma adiponectin, IL-6, hsCRP, and TNF-a levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital. Indian Journal of Endocrinology and Metabolism 16 769-776.(doi::10.4103/2230-8210.100672)